Current status: 974 hESC lines, 6269 hiPSC lines, and 153 clinical studies, and 2320 certificates
Monthly statistic from Jul 1, 2024
Posted on July 1, 2024
| total lines | 7243 |
| hESC lines | 974 |
| hiPSC lines | 6269 |
| derivation countries | 48 |
| projects | 303 |
| providers | 912 |
| clinical studies | 153 |
| subclones | 2882 |
| certificates | 2320 |
| cell line certificates | 2175 |
| project certificates | 145 |